Diego Muñoz‐Torrero

3.7k total citations
107 papers, 2.9k citations indexed

About

Diego Muñoz‐Torrero is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Diego Muñoz‐Torrero has authored 107 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pharmacology, 48 papers in Organic Chemistry and 32 papers in Molecular Biology. Recurrent topics in Diego Muñoz‐Torrero's work include Cholinesterase and Neurodegenerative Diseases (64 papers), Computational Drug Discovery Methods (32 papers) and Alzheimer's disease research and treatments (27 papers). Diego Muñoz‐Torrero is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (64 papers), Computational Drug Discovery Methods (32 papers) and Alzheimer's disease research and treatments (27 papers). Diego Muñoz‐Torrero collaborates with scholars based in Spain, Italy and United Kingdom. Diego Muñoz‐Torrero's co-authors include Pelayo Camps, F. Javier Luque, M. Victòria Clos, Albert Badı́a, Elisabet Viayna, Raimon Sabaté, Manuela Bartolini, Carles Galdeano, Belén Pérez and Jordi Morral and has published in prestigious journals such as Angewandte Chemie International Edition, Accounts of Chemical Research and PLoS ONE.

In The Last Decade

Diego Muñoz‐Torrero

103 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Muñoz‐Torrero Spain	31	1.9k	1.3k	1.3k	829	678	107	2.9k
Angela Rampa Italy	34	1.9k 1.0×	1.1k 0.8×	1.6k 1.3×	1.0k 1.2×	568 0.8×	117	3.5k
Silvia Gobbi Italy	33	1.6k 0.8×	969 0.7×	1.5k 1.1×	967 1.2×	479 0.7×	94	3.3k
Alessandra Bisi Italy	33	1.6k 0.9×	1.0k 0.7×	1.5k 1.2×	990 1.2×	492 0.7×	120	3.3k
Federica Belluti Italy	34	1.7k 0.9×	990 0.7×	1.6k 1.3×	1.0k 1.3×	520 0.8×	101	3.6k
Marco Catto Italy	38	2.0k 1.1×	1.3k 0.9×	2.3k 1.8×	1.2k 1.5×	492 0.7×	127	4.5k
Vincenzo Tumiatti Italy	29	1.9k 1.0×	1.2k 0.9×	1.1k 0.9×	1.3k 1.6×	714 1.1×	84	3.2k
Pelayo Camps Spain	30	1.5k 0.8×	970 0.7×	2.0k 1.6×	920 1.1×	388 0.6×	164	3.4k
Ling Huang China	36	1.8k 0.9×	876 0.7×	1.4k 1.1×	952 1.1×	743 1.1×	86	3.5k
Anna Minarini Italy	34	2.5k 1.3×	1.6k 1.2×	1.4k 1.1×	1.8k 2.2×	969 1.4×	112	4.4k
Leonardo Pisani Italy	29	1.4k 0.7×	738 0.5×	1.5k 1.1×	810 1.0×	260 0.4×	74	3.0k

Countries citing papers authored by Diego Muñoz‐Torrero

Since Specialization

Citations

This map shows the geographic impact of Diego Muñoz‐Torrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Muñoz‐Torrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Muñoz‐Torrero more than expected).

Fields of papers citing papers by Diego Muñoz‐Torrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Muñoz‐Torrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Muñoz‐Torrero. The network helps show where Diego Muñoz‐Torrero may publish in the future.

Co-authorship network of co-authors of Diego Muñoz‐Torrero

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Muñoz‐Torrero. A scholar is included among the top collaborators of Diego Muñoz‐Torrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Muñoz‐Torrero. Diego Muñoz‐Torrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teixidó, Elisabet, et al.. (2025). Combining the zebrafish embryo developmental toxicity assay (ZEDTA) with hemoglobin staining to accelerate the research of novel antimalarial drugs for pregnant women. International Journal for Parasitology Drugs and Drug Resistance. 27. 100582–100582.

Popovici, Jean, Antonino N. Fallica, Javier Moreno, et al.. (2025). YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates. Scientific Reports. 15(1). 2941–2941.

Muñoz‐Torrero, Diego, Lawrence M. Schopfer, & Oksana Lockridge. (2023). Chlorpyrifos Oxon Activates Glutamate and Lysine for Protein Cross-linking. Chemical Research in Toxicology. 36(1). 112–121. 3 indexed citations

Jemioła‐Rzemińska, Małgorzata, et al.. (2023). A rhein-huprine hybrid protects erythrocyte membrane integrity against Alzheimer’s disease related Aβ(1-42) peptide. Biophysical Chemistry. 300. 107061–107061. 3 indexed citations

Cano, Amanda, Elena Sánchez‐López, Jordi Olloquequi, et al.. (2023). A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet. Cell & Bioscience. 13(1). 52–52. 8 indexed citations

Gonçalves, Ana Elisa, Claudia Albertini, Jana Janočková, et al.. (2022). Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease. ACS Chemical Neuroscience. 13(23). 3314–3329. 12 indexed citations

Griñán‐Ferré, Christian, et al.. (2022). A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer’s Disease Mice Models. Pharmaceuticals. 15(8). 908–908. 6 indexed citations

Giménez‐Llort, Lydia, Belén Pérez, Pelayo Camps, et al.. (2021). Clock/Sleep-Dependent Learning and Memory in Male 3xTg-AD Mice at Advanced Disease Stages and Extrinsic Effects of Huprine X and the Novel Multitarget Agent AVCRI104P3. Brain Sciences. 11(4). 426–426. 3 indexed citations

Turcu, Andreea L., Marta Barniol‐Xicota, Alba Espargaró, et al.. (2019). A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. European Journal of Medicinal Chemistry. 180. 613–626. 25 indexed citations

10.

Pérez, Belén, Pelayo Camps, Diego Muñoz‐Torrero, et al.. (2018). Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice. International Journal of Molecular Sciences. 19(9). 2615–2615. 3 indexed citations

11.

Pietro, Ornella Di, Gerard Esteban, Elisabet Viayna, et al.. (2016). Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 24(20). 4835–4854. 23 indexed citations

12.

Pietro, Ornella Di, Jordi Juárez‐Jiménez, Alba Espargaró, et al.. (2014). Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies. European Journal of Medicinal Chemistry. 84. 107–117. 51 indexed citations

13.

Pietro, Ornella Di, Alba Espargaró, Anna Vallverdú‐Queralt, et al.. (2014). Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties. Bioorganic & Medicinal Chemistry. 22(19). 5298–5307. 37 indexed citations

14.

Pietro, Ornella Di, Elisabet Viayna, Esther Vicente‐García, et al.. (2013). 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: Synthesis, pharmacological evaluation and mechanistic studies. European Journal of Medicinal Chemistry. 73. 141–152. 39 indexed citations

15.

Viayna, Elisabet, Raimon Sabaté, & Diego Muñoz‐Torrero. (2013). Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates. Current Topics in Medicinal Chemistry. 13(15). 1820–1842. 67 indexed citations

16.

Pera, Marta, et al.. (2013). Undifferentiated and Differentiated PC12 Cells Protected by Huprines Against Injury Induced by Hydrogen Peroxide. PLoS ONE. 8(9). e74344–e74344. 18 indexed citations

17.

Muñoz‐Torrero, Diego, Marta Pera, Carles Galdeano, et al.. (2012). Expanding the Multipotent Profile of Huprine-Tacrine Heterodimers as Disease-Modifying Anti-Alzheimer Agents. Neurodegenerative Diseases. 10(1-4). 96–99. 5 indexed citations

18.

Galdeano, Carles, Elisabet Viayna, Pau Arroyo, et al.. (2010). Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents. Current Pharmaceutical Design. 16(25). 2818–2836. 49 indexed citations

19.

Camps, Pelayo & Diego Muñoz‐Torrero. (2002). Cholinergic Drugs in Pharmacotherapy of Alzheimers Disease. Mini-Reviews in Medicinal Chemistry. 2(1). 11–25. 48 indexed citations

20.

Aleu, Jordi, Inmaculada Gómez de Aranda, Diego Muñoz‐Torrero, et al.. (2001). The pharmacology of novel acetylcholinesterase inhibitors, (±)-huprines Y and X, on the Torpedo electric organ. European Journal of Pharmacology. 421(2). 77–84. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact